Skip to main content
Advertisement
Advertisement

PLSE

PLSE logo

Pulse Biosciences, Inc Common Stock (DE)

52.69
USD
Sponsored
-0.62
-1.16%
Sep 22, 15:59 UTC -4
Closed
exchange

Pre-Market

53.28

+0.59
+1.12%

PLSE Earnings Reports

Positive Surprise Ratio

PLSE beat 12 of 25 last estimates.

48%

Next Report

Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$663.00K
/
-$0.37
Implied change from Q2 26 (Revenue/ EPS)
+52.76%
/
+2.78%
Implied change from Q3 25 (Revenue/ EPS)
+670.93%
/
+32.14%

Pulse Biosciences, Inc Common Stock (DE) earnings per share and revenue

On Aug 06, 2026, PLSE reported earnings of -0.36 USD per share (EPS) for Q2 26, beating the estimate of -0.36 USD, resulting in a 1.96% surprise. Revenue reached 434.00 thousand, compared to an expected 544.00 thousand, with a -20.22% difference. The market reacted with a +10.90% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.37 USD, with revenue projected to reach 663.00 thousand USD, implying an increase of 2.78% EPS, and increase of 52.76% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
NANO-X IMAGING LTD Ordinary Shares
Report Date
Sep 09, 2026 For Q2 26
Estimate
-$0.16
Actual
-$0.80
Surprise
-380.19%
FAQ
For Q2 2026, Pulse Biosciences, Inc Common Stock (DE) reported EPS of -$0.36, beating estimates by 1.96%, and revenue of $434.00K, -20.22% below expectations.
The stock price moved up 10.9%, changed from $38.24 before the earnings release to $42.41 the day after.
The next earning report is scheduled for Nov 03, 2026.
Based on 3 analysts, Pulse Biosciences, Inc Common Stock (DE) is expected to report EPS of -$0.37 and revenue of $663.00K for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement